Literature DB >> 3137611

Apomorphine doses impair the reaction time of fast reacting but not slow reacting rats.

R E Wilcox1, W W Spirduso.   

Abstract

Previously, several studies in our laboratories have linked the ability to initiate movement rapidly (reactive capacity) in several rat strains to markers of nigrostriatal dopamine function. In the present investigation we wished to determine the extent to which fast-reacting (FR) and slow-reacting (SR) rats responded differentially to the effects of dopamine agonist (apomorphine) administration. Fisher 344 rats were operantly conditioned on a shock-avoidance, reactive capacity task which requires extremely fast, ballistic, lever release responses. In FR, but not in SR rats, significant dose-dependent decreases in the per cent of successful avoidance trials were observed in response to apomorphine doses. Moreover, apomorphine brought responding in the FR animals to levels below that of the SR rats. Performance of the SR rats was unaffected by drug treatments. A number of interpretations are consistent with these preliminary data, including the idea that basal differences in speed of reaction and differential responses to a dopamine agonist, antiparkinsonian agent may both be associated with a similar mechanism: differential activation of compartmentalized striatal efferent systems.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137611     DOI: 10.1007/bf00174524

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system.

Authors:  J Scheel-Krüger
Journal:  Acta Neurol Scand Suppl       Date:  1986

2.  Movement initiation characteristics in young adult rats in relation to the high- and low-affinity agonist states of the striatal D2 dopamine receptor.

Authors:  R E Wilcox; E Mudie; D Mayfield; R K Young; W W Spirduso
Journal:  Brain Res       Date:  1988-03-08       Impact factor: 3.252

3.  Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum.

Authors:  M Herkenham; C B Pert
Journal:  Nature       Date:  1981-06-04       Impact factor: 49.962

Review 4.  The classification of dopamine receptors: relationship to radioligand binding.

Authors:  I Creese; D R Sibley; M W Hamblin; S E Leff
Journal:  Annu Rev Neurosci       Date:  1983       Impact factor: 12.449

5.  Effects of aerobic training on reactive capacity: an animal model.

Authors:  W W Spirduso; R P Farrar
Journal:  J Gerontol       Date:  1981-11

6.  Strain differences in dopamine receptor function and the initiation of movement.

Authors:  M D Wolf; R E Wilcox; W H Riffee; L D Abraham
Journal:  Pharmacol Biochem Behav       Date:  1980-07       Impact factor: 3.533

7.  Quantification of lesion-induced dopaminergic supersensitivity using the rotational model in the mouse.

Authors:  R J Mandel; P K Randall
Journal:  Brain Res       Date:  1985-03-25       Impact factor: 3.252

8.  The effects of apomorphine on leverpress shock escape learning in rats.

Authors:  B A Mattingly
Journal:  Pharmacol Biochem Behav       Date:  1986-09       Impact factor: 3.533

9.  Activation of specific central dopamine pathways: locomotion and footshock.

Authors:  S G Speciale; J D Miller; B A McMillen; D C German
Journal:  Brain Res Bull       Date:  1986-01       Impact factor: 4.077

10.  Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle.

Authors:  H S Pan; J B Penney; A B Young
Journal:  J Neurochem       Date:  1985-11       Impact factor: 5.372

View more
  2 in total

1.  Amphetamine, cocaine, and dizocilpine enhance performance on a lever-release, conditioned avoidance response task in rats.

Authors:  I M White; J R Christensen; G S Flory; D W Miller; G V Rebec
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

2.  Saccadic latency distributions in Parkinson's disease and the effects of L-dopa.

Authors:  A W Michell; Z Xu; D Fritz; S J G Lewis; T Foltynie; C H Williams-Gray; T W Robbins; R H S Carpenter; R A Barker
Journal:  Exp Brain Res       Date:  2006-03-17       Impact factor: 1.972

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.